Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review

Date: November 24, 2015
Pages: 38
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review
Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Hovid Berhad (Hovid) is a pharmaceutical company that manufactures and commercializes pharmaceutical and herbal products. The company’s product portfolio consists of ethical drugs, pharmaceutical products, dietary supplements, tocotreienols and herbal tea. Hovid also specializes in special drug delivery systems including modified release formulations and bio-availability enhanced formulations. The company offers consumer products ranging from skin care, hair care and health beverages. Its research and development activities include drug delivery systems, nanotechnology research, clinical research, product development and specialized systems. The company has operations in Asia, Africa, the Americas, Europe, and the Pacific Island. Hovid is headquartered in Ipoh, Perak, Malaysia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company

Hovid Berhad - Key Facts
Hovid Berhad - Key Employees
Hovid Berhad - Major Products and Services
Hovid Berhad - History
Hovid Berhad - Company Statement
Hovid Berhad - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture


Hovid Berhad - Business Description
Hovid Berhad - Corporate Strategy
Hovid Berhad - SWOT Analysis
SWOT Analysis - Overview
Hovid Berhad - Strengths
Strength - Research and Development Capabilities
Strength - Comprehensive Offerings
Strength - Distribution Network
Hovid Berhad - Weaknesses
Weakness - Decline in Asian Geographical segment
Hovid Berhad - Opportunities
Opportunity - Potential in the Malaysian Healthcare Industry
Opportunity - Market for Generics Exports
Opportunity - Business Initiatives
Hovid Berhad - Threats
Threat - Uncertain R&D Outcomes
Threat - Competitive Landscape
Threat - Stringent Government Regulations
Hovid Berhad - Key Competitors


Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts


Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Hovid Berhad, Recent Deals Summary


Ratio Definitions
About GlobalData
Contact Us
Disclaimer 38


Hovid Berhad, Key Facts
Hovid Berhad, Key Employees
Hovid Berhad, Major Products and Services
Hovid Berhad, History
Hovid Berhad, Subsidiaries
Hovid Berhad, Joint Venture
Hovid Berhad, Key Competitors
Hovid Berhad, Ratios based on current share price
Hovid Berhad, Annual Ratios
Hovid Berhad, Interim Ratios
Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Hovid Berhad, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios 37


Hovid Berhad, Performance Chart (2011 - 2015)
Hovid Berhad, Ratio Charts
Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Hovid Berhad, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top

Camfil AB - Strategic SWOT Analysis Review US$ 125.00 May, 2016 · 28 pages

Ask Your Question

Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: